Veterinary Sciences· 2026Q1
Development and Preliminary Validation of a Recombinant DP238L-Based Indirect ELISA for the Serological Detection of African Swine Fever Virus Antibodies
- 0citations
- Q1SCImago
- 2026year
Short summary
A new indirect ELISA (DP238L-iELISA) using a recombinant viral protein (DP238L) detects African Swine Fever Virus (ASFV) antibodies with 98.3% overall agreement and 97.2% positive agreement compared to a commercial ELISA.
AI-generated from the title and abstract; the full text is not read.
Key points
- A novel indirect ELISA (DP238L-iELISA) was developed using recombinant DP238L antigen for ASFV antibody detection.
- The DP238L-iELISA achieved high diagnostic performance with 98.3% overall agreement and 97.2% positive agreement against a commercial ELISA.
- ROC analysis showed an AUC of 0.9989, indicating excellent discriminatory ability.
- The assay detected antibodies in experimentally infected pigs by 7 days post-infection.
AI-generated from the title and abstract; the full text is not read.
Abstract
African swine fever virus (ASFV) antibody detection is an important component of serological surveillance and retrospective investigations. DP238L was recently identified by proteome-wide serum-antibody profiling as a frequently recognized ASFV antigen, and recombinant DP238L was further shown to react with ASFV-positive sera and to elicit antigen-specific antibody responses in immunized pigs. Here, we extend those observations toward diagnostic assay development and preliminary validation. Full-length DP238L from ASFV strain SY-1 (GenBank OM161110) was evaluated as a single recombinant coating antigen for an indirect ELISA (DP238L-iELISA). Independent sequence analysis showed that SY-1 DP238L contains 238 amino acids, with a theoretical molecular mass of 27.13 kDa, a theoretical pI of 4.92, and a GRAVY value of −0.97. In a quality-restricted subset of complete, unambiguous 238-aa homologs (n = 7), amino acid identity to SY-1 ranged from 97.48% to 100% (median, 98.74%). Recombinant DP238L was expressed and purified from Escherichia coli and specifically recognized by ASFV-positive swine serum. ELISA optimization identified a coating antigen concentration of 0.5 μg/mL, a secondary-antibody working dilution of 1:2500 (0.4 μg/mL), a serum dilution of 1:100, a serum incubation time of 45 min, and a substrate development time of 15 min. Using 518 clinical swine serum samples categorized according to the commercial INgezim PPA COMPAC K3 blocking ELISA, ROC analysis yielded an AUC of 0.9989 (bootstrap 95% CI, 0.9973–0.9999). At the selected S/P cutoff of 0.30, positive percent agreement and negative percent agreement relative to INgezim were 97.2% and 98.7%, respectively; overall agreement was 98.3% and Cohen’s κ was 0.956. A limited six-sample heterologous panel provided preliminary cross-reactivity information, with all tested samples remaining below the cutoff. In a longitudinal panel from five experimentally infected pigs, three animals exceeded the cutoff at 7 days post-infection (dpi) and all five exceeded it by 10 dpi. These findings support DP238L as a promising recombinant antigen for ASFV serological assay development while emphasizing that the present results represent an internal comparator-based preliminary evaluation requiring broader independent validation.
The authors' abstract, as published at the source. Veterinary Sciences, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Agronomy and Crop Science
Agronomy and Crop ScienceAgricultural and Biological Sciences